Inefficient Research & development and reimbursement policies are primary factors restraining the market. Furthermore, as the market is in nascent stage, strict regulatory implications are also expected to deter growth. However, as the vaccine carries potential to treat many chronic diseases, these restraints would get weaker with time. This report delivers micro level analysis of the therapeutic vaccine market and its opportunities in various disease treatments.
Key market players profiled in this report include Affiris, Antigenics, Argos Therapeutics, Bavarian Nordic, Biovest International, Celldex Therapeutics, Cel-Sci, Celtic Pharma, Curevac And Cytos Biotechnology.
The report provides strategic analysis of the current market trend and delivers expected trends that would assist stakeholders to take strategic and actionable decisions
Present market quantitative scenario and estimations through 2013-2020
Analysis of the market factors in various geographic regions and help understand business opportunities
Identification of key investment pockets for various applications, services and geographies
Identification of key players and their business performance analysis based on strategies followed by them
Identification of key application segments based on future potential and growth prospects
Top factors affecting the market and analysis of probable changes in impact of those factors
Analysis and evaluation of market trends to provide deep-dive intelligence into every market segment
Competitive analysis based on strategies followed by key players to effectively plan and execute business plan
Micro level analysis based on application, service and geography
KEY MARKET SEGMENTS
Cocaine Addiction Vaccines
Nicotine Addiction Vaccines
Autoimmune Disease Vaccines
Diabetes (Type 1)
Cancer vaccines in development
Cancer vaccines approved for use
Infectious Disease Vaccines
Other infectious disease vaccines (outside HIV)
Neurological disease vaccines
Parkinson’s disease vaccine
Other disease vaccines
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.